Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
Clinical trial NCT05291091 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05291091
- Sponsor
- Edgewise Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-10
- Primary completion
- 2026-09-01
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.